Healthcare
from24/7 Wall St.
9 hours agoWall Street Sees 84% Upside in Hims & Hers (HIMS) Despite This Month's 48% Selloff
Hims & Hers plunged ~48% after FDA action and a patent lawsuit, yet analysts project substantial upside based on subscriber growth and revenue strength.